| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 09/04/2002 | CN1366911A Nano Naolejing preparation medicine and preparation method thereof |
| 09/04/2002 | CN1366899A Nano dizziness-clearing preparation medicine and preparation method thereof |
| 09/04/2002 | CN1366887A Nano amber dragon-embracing preparation medicine and preparation method thereof |
| 09/04/2002 | CN1090190C Heterocycle-condensed morphinoid derivatives and its preparing method and use |
| 09/04/2002 | CN1090189C Pyrazolopyrimidines type compound |
| 09/04/2002 | CN1090026C Novel medicine for stopping narcotics and preparing method thereof |
| 09/04/2002 | CN1090025C Medicated wine for treating pain in waist and lower extremities and rheumatic arthritis, and its producing method |
| 09/03/2002 | US6444829 (2s,4r)-4-mercapto-1-(naphthalene-2-sulfonyl)-pyrrolidine-2 -carboxylic acid n'-isobutyl-n'-(4-methyl-benzenesulfonyl)-hydrazide, for example; inhibitors of metalloproteases, e.g. zinc proteases; vasodilators |
| 09/03/2002 | US6444822 Antidepressants |
| 09/03/2002 | US6444811 Central nervous system disorders; cardiovascular disorders |
| 09/03/2002 | US6444802 Human aminopeptidase |
| 09/03/2002 | US6444793 Hydrophobically-modified hedgehog protein compositions and methods |
| 09/03/2002 | US6444708 Treatment using venlafaxine |
| 09/03/2002 | US6444702 Central nervous system disorders |
| 09/03/2002 | US6444696 1-aryl or heteroaryl substituted 5-amino-4 carbonylpyrazole derivatives; antiinflammatory agents |
| 09/03/2002 | US6444679 Neurological and gastrointestinal disorders; delta opioid ligands or opioid receptors |
| 09/03/2002 | US6444677 5-membered heteroaryl substituted 1,4-dihydropyridine compounds as bradykinin antagonists |
| 09/03/2002 | US6444674 High affinity for the dopamine d3 receptor; schizophrenia, depression, neuroses and psychoses |
| 09/03/2002 | US6444673 Optically active 5H-pyrrolo[3,4-b]pyrazine derivative, its preparation and pharmaceutical compositions containing it |
| 09/03/2002 | US6444662 Stable hyperforin salts, method for producing same and their use in the treatment of alzheimer's disease |
| 09/03/2002 | US6444657 2-(phosphonomethyl)pentanedioic acid; 2-(2-sulfanylethyl) pentanedioic acid; epithelial tissue scarring, collagen vascular disease, fibroproliferation, connective tissue disorder, respiratory distress syndrome; tgf regulator |
| 09/03/2002 | US6444643 Methods of using inhibitors of cyclophilin rotamase activity to affect neurological activity |
| 09/03/2002 | US6444642 Administering to mammal effective amount of neuregulin polypeptide with p185.sup.erbb2 protein binding activity to stimulate myogenesis of muscle cells |
| 09/03/2002 | US6444639 Human chorionic gonadotrophin (hcg) used to treat or prevent tumors, multiple sclerosis, inflammation or angiogenesis-dependent diseases |
| 09/03/2002 | US6444203 Administering bacteria to improve sleep |
| 09/03/2002 | US6444201 Therapy for nervous system disorders |
| 09/03/2002 | CA2237189C 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists |
| 09/03/2002 | CA2234051C Novel isoquinoline derivatives |
| 09/01/2002 | CA2373596A1 Combination treatment for depression, obsessive compulsive disorder, and psychosis |
| 09/01/2002 | CA2373578A1 .beta.3, agonists and uses thereof |
| 08/29/2002 | WO2002066978A2 Detection of compounds that modulate inflammatory responses |
| 08/29/2002 | WO2002066681A2 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors |
| 08/29/2002 | WO2002066672A2 Treatment of cns disorders using d-amino acid oxidase and d-aspartate oxidase antagonists |
| 08/29/2002 | WO2002066647A2 Type 2 ctokine receptor and nucleic acids encoding same |
| 08/29/2002 | WO2002066646A2 Neurotransmission-associated proteins |
| 08/29/2002 | WO2002066635A1 Transgenic animal having drug metabolism enzyme gene and utilization thereof |
| 08/29/2002 | WO2002066516A2 Antibodies that bind both bcma and taci |
| 08/29/2002 | WO2002066494A2 Identification and cloning of a novel human gene, ret16, involved in the intracellular signaling cascade |
| 08/29/2002 | WO2002066484A1 Isoxazoline derivatives as anti-depressants |
| 08/29/2002 | WO2002066480A2 2-arylamino-pyrimidines for the treatment of gsk3-related disorders |
| 08/29/2002 | WO2002066476A1 6-phenylbenzonaphthyridines |
| 08/29/2002 | WO2002066473A1 8’4-’3-(5-fluoro-1h-indol-3yl) propyl!-1-piperazynyl!-2-methyl-2h-1,4-benzoxazin -3 (4h)- one methanesulfonate with high affinity for the dopamine d 2 receptor and the serotonin reuptake site |
| 08/29/2002 | WO2002066472A1 New phenylpiperazines |
| 08/29/2002 | WO2002066469A2 Novel heterocyclic amide derivatives and their use as dopamine d3 receptor ligands |
| 08/29/2002 | WO2002066468A2 Heterocyclic urea derivatives and their use as dopamine d3 receptor ligands |
| 08/29/2002 | WO2002066466A1 Process to produce paroxetine |
| 08/29/2002 | WO2002066461A1 Pyrazole compounds useful as protein kinase inhibitors |
| 08/29/2002 | WO2002066458A2 2-thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry |
| 08/29/2002 | WO2002066456A2 Thiophene substituted amine derivatives as glyt-1 inhibitors |
| 08/29/2002 | WO2002066453A1 Process for the preparation of citalopram |
| 08/29/2002 | WO2002066450A2 Anthrone derivatives and their use as ink inhibitors |
| 08/29/2002 | WO2002066447A1 4h-1,2,4-triazole-3(2h)-thione deratives as sphingomyelinase inhibitors |
| 08/29/2002 | WO2002066446A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands |
| 08/29/2002 | WO2002066432A1 Substituted propane-1,3-diamine derivatives and the pharmaceutical use thereof |
| 08/29/2002 | WO2002066431A1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same |
| 08/29/2002 | WO2002066430A1 Tryptase inhibitors |
| 08/29/2002 | WO2002066427A2 (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions and uses thereof |
| 08/29/2002 | WO2002066426A2 Fluoro oxindole derivatives as modulators of kcnq potassium channels |
| 08/29/2002 | WO2002066422A1 Phenethanolamine derivatives for treatment of respiratory diseases |
| 08/29/2002 | WO2002066420A2 Tryptase inhibitors |
| 08/29/2002 | WO2002066068A2 Method of treating neurological diseases |
| 08/29/2002 | WO2002066050A1 Casoase 3 inhibitors |
| 08/29/2002 | WO2002066043A2 Use of a polyfunctional active substance mixture as an antagonist against harmful substances contained in tobacco smoke |
| 08/29/2002 | WO2002066041A1 Natural composition |
| 08/29/2002 | WO2002066040A2 Sensitization of chemotherapeutic agent resistant neoplastic cells with reovirus |
| 08/29/2002 | WO2002066036A1 2,4-disubstituted pyrimidine-5-carboxamide derivatives as kcnq potassium channel modulators |
| 08/29/2002 | WO2002066032A1 Treatment of schizophrenia |
| 08/29/2002 | WO2002066031A1 Utilization of buprenorphine in urinary incontinence therapy |
| 08/29/2002 | WO2002066030A1 Medicinal compositions comprising diclofenac and ornoprostil |
| 08/29/2002 | WO2002066026A2 Tramadol-based medicament |
| 08/29/2002 | WO2002066023A1 Use of a cyclohexenone derivatives in the manufacture of a medicament for treating diabetic complications |
| 08/29/2002 | WO2002066020A2 Modulation of gsk-3beta activity and its different uses |
| 08/29/2002 | WO2002065985A2 Methods of treating diabetes mellitus |
| 08/29/2002 | WO2002065979A2 (diazolo-pyridinyl)-pyrimidines for use in treatment of cns disorders and diabetes |
| 08/29/2002 | WO2002065978A2 Functional agent for decomposing nicotine and method of preparing the same |
| 08/29/2002 | WO2002065977A2 Compounds co-inducing cholinergic up-regulation and inflammation down-regulation and uses thereof |
| 08/29/2002 | WO2002065859A1 Emulsions and aqueous dispersions of phytosterols |
| 08/29/2002 | WO2002045753A3 Oral extended release formulation of gepirone |
| 08/29/2002 | WO2002042273A3 Acid derivatives useful as serine protease inhibitors |
| 08/29/2002 | WO2002040466A3 Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives for treating of nervous systems disorders |
| 08/29/2002 | WO2002039991A3 Prevention of development of dyskinesias |
| 08/29/2002 | WO2002028867A3 Ethers of 7-desmethylrapamycin for use in immunosuppression |
| 08/29/2002 | WO2002028858A3 Hexahydropyrazino `1'2' : 1, 6!- pyrido `3, 4-b! indole-1, 4-dione derivatives for the treatment of cardiovascular disorders and erectile disfunction |
| 08/29/2002 | WO2002020723A3 Compositions and methods for targeting peptides in humans in vivo |
| 08/29/2002 | WO2002010403A3 Regulation of human phosphatidylinositol-specific phospholipase c-like enzyme |
| 08/29/2002 | WO2002010388A3 C3b/C4b COMPLEMENT RECEPTOR-LIKE MOLECULES AND USES THEREOF |
| 08/29/2002 | WO2002003988A3 Use of substituted indole compounds for treating neuropeptide y-related conditions |
| 08/29/2002 | WO2002002520A3 Compounds to treat alzheimer's disease |
| 08/29/2002 | WO2002002506A3 Compounds to treat alzheimer's disease |
| 08/29/2002 | WO2001096547A3 Human kinases |
| 08/29/2002 | WO2001090758A3 Diagnosis of alzheimer's disease ldl receptor protein-1 |
| 08/29/2002 | WO2001085093A3 Compounds and methods for modulating cerebral amyloid angiopathy |
| 08/29/2002 | WO2001082975A3 Membrane-permeant peptide complexes for medical imaging |
| 08/29/2002 | WO2001077338A3 Human protein kinases and protein kinase-like enzymes |
| 08/29/2002 | WO2001037785A9 Novel methods and compositions involving opioids and antagonists thereof |
| 08/29/2002 | WO2001012584A3 Pharmaceutical compounds |
| 08/29/2002 | WO2000068188A9 Propanoic acid derivatives that inhibit the binding of integrins to their receptors |
| 08/29/2002 | WO2000067746A9 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 08/29/2002 | WO2000066737A9 VARIANTS OF TRAF2 WHICH ACT AS AN INHIBITOR OF TNF-ALPHA (TNF α) SIGNALING PATHWAY |
| 08/29/2002 | WO2000066104A9 Ace-2 inhibiting compounds and methods of use thereof |